511 related articles for article (PubMed ID: 27565569)
41. Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.
Bretagne CH; Jooste V; Guenat D; Riethmuller D; Bouvier AM; Bedgedjian I; Prétet JL; Valmary-Degano S; Mougin C
J Gynecol Obstet Hum Reprod; 2018 Dec; 47(10):525-531. PubMed ID: 29807205
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.
Ngabo F; Franceschi S; Baussano I; Umulisa MC; Snijders PJ; Uyterlinde AM; Lazzarato F; Tenet V; Gatera M; Binagwaho A; Clifford GM
BMC Infect Dis; 2016 May; 16():225. PubMed ID: 27221238
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.
AlObaid A; Al-Badawi IA; Al-Kadri H; Gopala K; Kandeil W; Quint W; Al-Aker M; DeAntonio R
BMC Infect Dis; 2014 Dec; 14():643. PubMed ID: 25496614
[TBL] [Abstract][Full Text] [Related]
44. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.
Shi N; Lu Q; Zhang J; Li L; Zhang J; Zhang F; Dong Y; Zhang X; Zhang Z; Gao W
Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28409676
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of Human Papillomavirus Genotypes in Women from Cozumel, Mexico.
Navarro-Vidal E; Hernandez-Rosas F; Rey M; Flores-Peredo L
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2417-2422. PubMed ID: 30255694
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study.
Baddal B; Oktay MN; Bostanci A; Yenen MC
BMC Womens Health; 2023 Jun; 23(1):297. PubMed ID: 37270608
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
Kudo R; Sekine M; Yamaguchi M; Hara M; Hanley SJB; Kurosawa M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Cancer Sci; 2022 Sep; 113(9):3211-3220. PubMed ID: 35730321
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and genotype distribution of cervical human papilomavirus infection in the pre-vaccination era: a population-based study in the Canary Islands.
Andujar M; Roura E; Torres A; Vega B; Pavcovich M; Sanchez MA; Lubrano A; Trujillo JL; Almeida L; Santana M; Hurtado R; Arencibia O; Benito V; Medina N; Carballo S; Camacho MDC; Ruiz Del Pozo A; Quesada A; Salido E; de Sanjosé S; Bruni L; ;
BMJ Open; 2020 Sep; 10(9):e037402. PubMed ID: 32973061
[TBL] [Abstract][Full Text] [Related]
49. Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands.
Lenselink CH; Melchers WJ; Quint WG; Hoebers AM; Hendriks JC; Massuger LF; Bekkers RL
PLoS One; 2008; 3(11):e3743. PubMed ID: 19011683
[TBL] [Abstract][Full Text] [Related]
50. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
51. [Prevalence of human papillomavirus genotypes in Bulgarian women with atypical cervical lesions examined by colposcopy].
Kovachev S; Nacheva A
Akush Ginekol (Sofiia); 2010; 49(4):25-31. PubMed ID: 20734638
[TBL] [Abstract][Full Text] [Related]
52. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
53. Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer.
Abudukadeer A; Azam S; Mutailipu AZ; Qun L; Guilin G; Mijiti S
World J Surg Oncol; 2015 Mar; 13():110. PubMed ID: 25885660
[TBL] [Abstract][Full Text] [Related]
54. High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
Litwin C; Smith L; Donken R; Krajden M; van Niekerk D; Naus M; Cook D; Albert A; Ogilvie G
Vaccine; 2021 Aug; 39(36):5198-5204. PubMed ID: 34344555
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
56. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
57. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
Roura E; Iftner T; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; Rodriguez MS; Morillo C; Serradell L; Torcel-Pagnon L; Cortes J; Castellsagué X;
BMC Infect Dis; 2012 Jun; 12():145. PubMed ID: 22734435
[TBL] [Abstract][Full Text] [Related]
58. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
[TBL] [Abstract][Full Text] [Related]
59. High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia.
Sainei NE; Kumar VS; Chin YS; Salih FAM
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2807-2813. PubMed ID: 30360610
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population.
Khoo SP; Bhoo-Pathy N; Yap SH; Anwar Shafii MK; Hairizan Nasir N; Belinson J; Subramaniam S; Goh PP; Zeng M; Tan HD; Gravitt P; Woo YL
Sex Transm Infect; 2018 Jun; 94(4):277-283. PubMed ID: 29180538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
